Italian Pharmaceuticals & Biotech Potentially Undervalued Companies

Sanofi

Market Cap: €106.6b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €180.7m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Merck

Market Cap: €191.8b

Operates as a healthcare company worldwide.

Merck KGaA

Market Cap: €50.2b

Operates as a science and technology company in Germany.

Bayer

Market Cap: €24.3b

Operates as a life science company worldwide.

Exact Sciences

Market Cap: €10.9b

Provides cancer screening and diagnostic test products in the United States and internationally.

Regeneron Pharmaceuticals

Market Cap: €64.0b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Organon

Market Cap: €2.5b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Johnson & Johnson

Market Cap: €369.5b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

CureVac

Market Cap: €1.0b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

BioMarin Pharmaceutical

Market Cap: €11.2b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Gerresheimer

Market Cap: €2.2b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Incyte

Market Cap: €12.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Pfizer

Market Cap: €133.3b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Viatris

Market Cap: €10.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Bristol-Myers Squibb

Market Cap: €97.4b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Biogen

Market Cap: €19.5b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Jazz Pharmaceuticals

Market Cap: €6.7b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Iovance Biotherapeutics

Market Cap: €611.1m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Thermo Fisher Scientific

Market Cap: €152.4b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Halozyme Therapeutics

Market Cap: €6.7b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Apellis Pharmaceuticals

Market Cap: €2.2b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Novartis

Market Cap: €184.2b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

Medpace Holdings

Market Cap: €8.5b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Axsome Therapeutics

Market Cap: €5.2b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Revvity

Market Cap: €10.8b

Provides health sciences solutions, technologies, and services worldwide.

Danaher

Market Cap: €136.3b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Krystal Biotech

Market Cap: €3.6b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Vaxcyte

Market Cap: €4.2b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Waters

Market Cap: €21.1b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Charles River Laboratories International

Market Cap: €6.8b

Charles River Laboratories International, Inc.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.8b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Revolution Medicines

Market Cap: €7.3b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Exelixis

Market Cap: €11.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

IQVIA Holdings

Market Cap: €24.4b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Agilent Technologies

Market Cap: €32.2b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.